SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

A third-party observers report and photo said POET was featured in Foxconns photonics ecosystem, reviving attention to POETs existing optical-engine collaboration with Foxconn Interconnect Technology. Traders view the display as validation of the partnership, while others say it is not proof of production shipments or purchase orders and want confirmation from POET.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor is drawing attention ahead of the FDAs Nov. 22 target decision on deramiocel for Duchenne muscular dystrophy. Many traders view new commercial hiring and signs of greater FDA flexibility as reasons for optimism, while others caution that hiring is no guarantee and point to the prior AdCom and unresolved efficacy concerns.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,809.831273 with 281,866,746.118905 in circulation. The last known price of OFFICIAL TRUMP is 1.73532194 USD and is up 9.97 over the last 24 hours. It is currently trading on 744 active market(s) with $259,407,006.57 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

A rebound in the Trump-themed meme coin is prompting short-term pump and short-squeeze speculation, but discussion is dominated by its steep losses and accusations that it is a low-utility pump-and-dump; some traders are buying the dip while others expect further declines.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its upcoming earnings report is driving discussion, with traders weighing concerns about advertising demand and weak signals from peers against bullish views that the companys growth and cash generation make the shares undervalued. The report is seen as a key test of whether the decline reflects a worsening business outlook or broader market and sector pressure.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

Traders are focused on the FDAs pending decision on whether to accept MoonLakes sonelokimab application for hidradenitis suppurativa and what review timeline it will receive. Bulls view the regulatory milestone and drugs commercial potential as catalysts, while bears cite approval uncertainty, competition, and concerns about the companys ability to commercialize alone and fund its plans.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

A sharp pullback after a volatile rally is dominating discussion, with traders debating profit-taking, broader biotech and genomics weakness, and short pressure; many say they see no clear TEM-specific trigger. Bulls point to Tempuss oncology and data partnerships and earnings prospects, while bears cite valuation and insider selling.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARAs steep selloff and trading near recent lows have focused discussion on the upcoming earnings report and whether the company can announce AI/data-center tenant leases; traders are skeptical about the lack of signed deals, while some expect a rebound if leases materialize. Bitcoins moves also shape sentiment toward the miner, with traders debating whether oversold conditions and heavy short interest could support a bounce.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings beat, supported by growth in Dupixent and Eylea HD, has driven a sharp breakout and renewed bullish attention. Traders are focused on whether newer products can offset pressure on legacy Eylea, with some also watching upcoming clinical and regulatory catalysts.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is drawing attention after a sharp gold selloff and a break of key support, with traders questioning why the traditional safe haven is falling alongside risk assets. The community is split between seeing more downside as Fed rate-hike expectations weigh on gold and viewing forced liquidations or margin calls as a temporary source of selling and a potential buying opportunity.

First Majestic Silver Corp. engages in the production, development, exploration, and acquisition of mineral properties, with a focus on silver and gold production in North America. It owns and operates producing mines in Mexico, including the Santa Elena Silver & Gold Mine, the Los Gatos Silver Mine, the San Dimas Silver & Gold Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA, which is currently in the process of restarting. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

AG is being discussed amid a sharp, volatile pullback in silver miners, with traders linking pressure to weaker silver prices and rising yields and rate-hike concerns. Bullish traders view the decline as a buying opportunity and remain optimistic about silver longer term, while bearish traders expect further downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CAPR ehh wake me up when obama takes his third term

BioSwings™

TopOptionsAlerts®

StockTwits For Android 

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is the dominant focus, with traders weighing the amended upper-limb data, recent rare-disease discussions and new commercial-launch job postings as possible signs of approval. Optimism and short-squeeze speculation are countered by warnings that hiring is not proof of an FDA outcome and that a CRL remains possible; INOs approval is also cited as a positive read-through, not confirmation for CAPR.

 ehh wake me up when obama takes his third term